Medical care cost savings from adolescent contraceptive use.
An analysis of the economic benefits of adolescent contraceptive use utilizes information from a national private payer database and from the California Medicaid program to compare private- and public-sector costs and savings. The study estimates the costs of acquiring and using 11 contraceptive methods appropriate for adolescents, treating associated side effects, providing medical care related to an unintended pregnancy during method use and treating sexually transmitted diseases (STDs) and compares them with the costs of using no method. The average annual cost per adolescent at risk of unintended pregnancy who uses no method is $1,267 ($1,079 for unintended pregnancy and $188 for STDs) in the private sector and $677 ($541 for unintended pregnancy and $137 for STDs) in the public sector under the most conservative assumptions. At one year of use, private-sector savings from adolescent contraceptive use range from $308 for the implant to $946 for the male condom; public-sector savings rise from $60 for the implant to $525 for the male condom. Both the use of male condoms with another method and the advance provision of backup emergency contraceptive pills provide additional savings.
Trussell
J
J
Woodrow Wilson School of Public and International Affairs, Princeton University, NJ, USA.
Koenig
J
J
Stewart
F
F
Darroch
J E
JE
D000293:Adolescent; D002140:California / Q000453:epidemiology; D003271:Contraceptive Agents, Female / Q000009:adverse effects / Q000191:economics*; D003273:Contraceptive Devices / Q000009:adverse effects / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D017048:Health Care Costs; D006801:Humans; D015994:Incidence; D008484:Medicaid / Q000191:economics; D011247:Pregnancy; D011253:Pregnancy in Adolescence / Q000706:statistics & numerical data; D017149:Private Sector; D017150:Public Sector; D012306:Risk; D012749:Sexually Transmitted Diseases / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology
D003271:Contraceptive Agents, Female